DCDiana Carolina Carolina Rodriguez Camargo

Diana Carolina Carolina Rodriguez Camargo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diana Carolina Carolina Rodriguez Camargo has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structural Insights into Seeding Mechanisms of hIAPP Fibril Formation

    by Saba Suladze, Christian Sustay Martinez, Diana C. Rodriguez Camargo, Jonas Engler, Natalia Rodina, Riddhiman Sarkar, Martin Zacharias, Bernd Reif

    The deposition of islet amyloid polypeptide (hIAPP) fibrils is a hallmark of β-cell death in type II diabetes. In this study, we employ state-of-the-art MAS solid-state spectroscopy to investigate the previously elusive N-terminal region of hIAPP fibrils, uncovering both rigidity and heterogeneity. Comparative analysis between wild-type hIAPP and a disulfide-deficient variant (hIAPPC2S,C7S) unveils shared fibril core structures yet strikingly distinct dynamics in the N-terminus. Specifically, the variant fibrils exhibit extended β-strand conformations, facilitating surface nucleation. Moreover, our findings illuminate the pivotal roles of specific residues in modulating secondary nucleation rates. These results deepen our understanding of hIAPP fibril assembly and provide critical insights into the molecular mechanisms underpinning type II diabetes, holding promise for future therapeutic strategies.


  • Small molecule induced toxic human-IAPP species characterized by NMR

    by Sarah J. Cox, Diana Carolina Carolina Rodriguez Camargo, Young-Ho Lee, Romeo Cosimo Arrigo Dubini, Petra Rovó, Magdalena I. Ivanova, Vediappen Padmini, Bernd Reif, Ayyalusamy Ramamoorthy

    In this study, the effect of CurDAc, a water-soluble curcumin derivative, on the formation and stability of amyloid fibers is revealed. CurDAc interaction with amyloid is structurally selective, which is reflected in a strong interference with hIAPP aggregation while showing weaker interactions with human-calcitonin and amyloid-β1–40 in comparison. Remarkably, CurDAc also exhibited potent fiber disaggregation for hIAPP generating a toxic oligomeric species.


  • Open Access

    Small Molecule Induced Toxic Human-IAPP Species Characterized by NMR

    by Sarah J. Cox, Diana C. Rodriguez Camargo, Young-Ho Lee, Magdalena I. Ivanova, Vediappen Padmini, Bernd Reif, Ayyalusamy Ramamoorthy

    In this study, the effect of CurDAc, a water-soluble curcumin derivative, on the formation and stability of amyloid fibers is revealed. CurDAc interaction with amyloid is structurally selective which is reflected in a strong interference with hIAPP aggregation, while showing weaker interactions with human-calcitonin and Amyloid-β 1-40 in comparison. Remarkably, CurDAc also exhibited potent fiber disaggregation for hIAPP generating a toxic oligomeric species.


  • hIAPP forms toxic oligomers in plasma

    by Diana C. Rodriguez Camargo, Divita Garg, Katalin Buday, Andras Franko, Andres Rodriguez Camargo, Fabian Schmidt, Sarah J. Cox, Saba Suladze, Martin Haslbeck, Yonatan G. Mideksa, et al.

    Glucose and lipid containing particles such as LDL interact with hIAPP, resulting in the formation of hIAPP oligomeric structures that yield an intrinsic fluorescence and toxicity in cellular assays.


  • Open Access

    Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate

    by Diana C Rodriguez Camargo, Kyle J Korshavn, Alexander Jussupow, Kolio Raltchev, David Goricanec, Markus Fleisch, Riddhiman Sarkar, Kai Xue, Michaela Aichler, Gabriele Mettenleiter, et al.

    Membrane-assisted amyloid formation is implicated in human diseases, and many of the aggregating species accelerate amyloid formation and induce cell death. While structures of membrane-associated intermediates would provide tremendous insights into the pathology and aid in the design of compounds to potentially treat the diseases, it has not been feasible to overcome the challenges posed by the cell membrane. Here, we use NMR experimental constraints to solve the structure of a type-2 diabetes related human islet amyloid polypeptide intermediate stabilized in nanodiscs. ROSETTA and MD simulations resulted in a unique β-strand structure distinct from the conventional amyloid β-hairpin and revealed that the nucleating NFGAIL region remains flexible and accessible within this isolated intermediate, suggesting a mechanism by which membrane-associated aggregation may be propagated. The ability of nanodiscs to trap amyloid intermediates as demonstrated could become one of the most powerful approaches to dissect the complicated misfolding pathways of protein aggregation.